GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » 3-Year RORE %

NantHealth (NantHealth) 3-Year RORE % : 0.38% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is NantHealth 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. NantHealth's 3-Year RORE % for the quarter that ended in Sep. 2023 was 0.38%.

The industry rank for NantHealth's 3-Year RORE % or its related term are showing as below:

NHIQ's 3-Year RORE % is ranked worse than
50.85% of 590 companies
in the Healthcare Providers & Services industry
Industry Median: 1.275 vs NHIQ: 0.38

NantHealth 3-Year RORE % Historical Data

The historical data trend for NantHealth's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NantHealth 3-Year RORE % Chart

NantHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only 2.93 -21.89 -43.82 -4.43 4.76

NantHealth Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.31 4.76 -16.00 2.92 0.38

Competitive Comparison of NantHealth's 3-Year RORE %

For the Health Information Services subindustry, NantHealth's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NantHealth's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where NantHealth's 3-Year RORE % falls into.



NantHealth 3-Year RORE % Calculation

NantHealth's 3-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -8.19--8.1 )/( -23.85-0 )
=-0.09/-23.85
=0.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 3-year before.


NantHealth  (OTCPK:NHIQ) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


NantHealth 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of NantHealth's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


NantHealth (NantHealth) Business Description

Traded in Other Exchanges
N/A
Address
3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500
NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.
Executives
Rao Haris Naseem director, 10 percent owner, officer: Chief Executive Officer C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc 10 percent owner 2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks officer: Chief Operating Officer C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong director, 10 percent owner, officer: See Remarks 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise director C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou officer: Interim CFO C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc. 10 percent owner 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait 10 percent owner 15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr director JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait 10 percent owner C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett director 640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049

NantHealth (NantHealth) Headlines

From GuruFocus

Nanthealth Inc (NH) CEO Patrick Soon-shiong Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor 04-16-2021

NantHealth to Present at the Cowen 42nd Annual Health Care Conference

By Business Wire Business Wire 03-07-2022